Related Experiment Video
Updated: Jan 5, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
NSD3S stabilizes MYC through hindering its interaction with FBXW7
Valentina Gonzalez-Pecchi1,2, Albert K Kwan2, Sean Doyle2
1Graduate Program in Cancer Biology, Emory University, Atlanta, GA, USA.
Abstract:
The MYC transcription factor plays a key role in cell growth control. Enhanced MYC protein stability has been found to promote tumorigenesis. Thus, understanding how MYC stability is controlled may have significant implications for revealing MYC-driven growth regulatory mechanisms in physiological and pathological processes. Our previous work identified the histone lysine methyltransferase nuclear receptor binding SET domain protein 3 (NSD3) as a MYC modulator. NSD3S, a noncatalytic isoform of NSD3 with oncogenic activity, appears to bind, stabilize, and activate the transcriptional activity of MYC. However, the mechanism by which NSD3S stabilizes MYC remains to be elucidated. To uncover the nature of the interaction and the underlying mechanism of MYC regulation by NSD3S, we characterized the binding interface between both proteins by narrowing the interface to a 15-amino acid region in NSD3S that is partially required for MYC regulation. Mechanistically, NSD3S binds to MYC and reduces the association of F-box and WD repeat domain containing 7 (FBXW7) with MYC, which results in suppression of FBXW7-mediated proteasomal degradation of MYC and an increase in MYC protein half-life. These results support a critical role for NSD3S in the regulation of MYC function and provide a novel mechanism for NSD3S oncogenic function through inhibition of FBXW7-mediated degradation of MYC.
Insights
The nuclear receptor binding SET domain protein 3 short isoform (NSD3S) stabilizes the MYC oncoprotein by blocking its degradation. This mechanism reveals a new pathway for NSD3S
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The MYC transcription factor is crucial for cell growth and its enhanced stability promotes cancer.
- Nuclear receptor binding SET domain protein 3 (NSD3), particularly its NSD3S isoform, has been identified as a MYC modulator.
- The precise mechanism by which NSD3S stabilizes MYC and contributes to oncogenesis is not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanism by which the NSD3S isoform stabilizes MYC.
- To characterize the binding interface between NSD3S and MYC.
- To investigate how NSD3S binding affects MYC degradation pathways.
Main Methods:
- Protein-protein interaction analysis to define the binding interface between NSD3S and MYC.
- Biochemical assays to assess the impact of NSD3S on MYC stability and degradation.
- Investigation of the role of FBXW7 (F-box and WD repeat domain containing 7) in NSD3S-mediated MYC regulation.
Main Results:
- The binding interface between NSD3S and MYC was narrowed to a 15-amino acid region in NSD3S.
- NSD3S binds to MYC and disrupts the interaction between MYC and the E3 ubiquitin ligase FBXW7.
- This disruption inhibits FBXW7-mediated proteasomal degradation of MYC, leading to increased MYC protein half-life and stability.
Conclusions:
- NSD3S stabilizes MYC by preventing its degradation via the FBXW7-mediated pathway.
- This novel mechanism highlights NSD3S's oncogenic function in promoting MYC stability.
- Understanding this interaction provides insights into MYC-driven tumorigenesis and potential therapeutic strategies.
More Related Videos
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Abnormal Proliferation
Regulation of Nuclear Protein Sorting
Destabilization of Microtubules
Restarting Stalled Replication Forks
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...

